{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:58:11Z","timestamp":1772783891604,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"IMSS\u2013FIS","award":["FIS\/IMSS\/PROT\/MD13\/1266"],"award-info":[{"award-number":["FIS\/IMSS\/PROT\/MD13\/1266"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.vaccine.2017.11.047","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T19:47:02Z","timestamp":1511812022000},"page":"292-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection"],"prefix":"10.1016","volume":"36","author":[{"given":"Guillermo","family":"Galvez-Romero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Salas-Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ericka N.","family":"Pompa-Mera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Ch\u00e1vez-Rueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Aguilar-Seti\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.11.047_b0005","doi-asserted-by":"crossref","first-page":"E279","DOI":"10.3390\/v8110279","article-title":"Rabies control and treatment: from prophylaxis to strategies with curative potential","volume":"8","author":"Zhu","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2017.11.047_b0010","unstructured":"WHO. WHO expert consultation on rabies. 2nd ed. Geneva: WHO technical report series; 2013."},{"key":"10.1016\/j.vaccine.2017.11.047_b0015","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1292\/jvms.16-0092","article-title":"The importance of immune evasion in the pathogenesis of rabies virus","volume":"78","author":"Ito","year":"2016","journal-title":"J Vet Med Sci"},{"key":"10.1016\/j.vaccine.2017.11.047_b0020","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1586\/14760584.2015.973403","article-title":"Rabies vaccines: where do we stand, where are we heading?","volume":"14","author":"Kaur","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.11.047_b0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.20506\/rst.33.1.2278","article-title":"Control of canine rabies in developing countries: key features and animal welfare implications","volume":"33","author":"Ar\u00e9chiga-Ceballos","year":"2014","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.vaccine.2017.11.047_b0030","first-page":"457","article-title":"Nouvelle Communications sur la rage","volume":"98","author":"Pasteur","year":"1884","journal-title":"CR Acad Sci"},{"key":"10.1016\/j.vaccine.2017.11.047_b0035","doi-asserted-by":"crossref","first-page":"e515","DOI":"10.1371\/journal.pntd.0000515","article-title":"Novel vaccines to humans rabies","volume":"3","author":"Ertl","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2017.11.047_b0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1134\/S0026893315040172","article-title":"Rabies vaccines: Current status and prospects for development","volume":"49","author":"Starodubova","year":"2015","journal-title":"Mol Biol (Mosk)"},{"key":"10.1016\/j.vaccine.2017.11.047_b0045","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/jvi.65.8.4198-4203.1991","article-title":"Antigenicity of rabies virus glycoprotein","volume":"65","author":"Benmansour","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0050","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1016\/j.vaccine.2010.08.082","article-title":"Rabies vaccines: WHO position paper\u2013recommendations","volume":"28","author":"Publication","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.047_b0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1099\/0022-1317-40-3-595","article-title":"Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine","volume":"40","author":"Turner","year":"1978","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0060","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1128\/JVI.72.5.3711-3719.1998","article-title":"Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system","volume":"72","author":"Hooper","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbiotec.2005.06.009","article-title":"High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice","volume":"119","author":"Ashraf","year":"2005","journal-title":"J Biotechnol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0070","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00705-010-0909-4","article-title":"Construction and immunogenicity of a recombinant pseudotype baculovirus expressing the glycoprotein of rabies virus in mice","volume":"156","author":"Huang","year":"2011","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1096\/fj.09-138644","article-title":"Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB\/c mice","volume":"24","author":"Kaur","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.vaccine.2017.11.047_b0080","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14760584.2016.1124762","article-title":"Molecular mechanisms for enhanced DNA vaccine immunogenicity","volume":"15","author":"Li","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.11.047_b0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/1743-422X-9-319","article-title":"Design of different strategies of multivalent DNA-based vaccination against rabies and canine distemper in mice and dogs","volume":"9","author":"Touihri","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2017.11.047_b0090","first-page":"627","article-title":"Enhancement of immunogenicity and efficacy of a plasmid DNA rabies vaccine by nanoformulation with a fourth-generation amine-terminated poly(ether imine) dendrimer","volume":"9","author":"Ullas","year":"2014","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.vaccine.2017.11.047_b0095","first-page":"223","article-title":"A comparative approach between heterologous prime-boost vaccination strategy and DNA vaccinations for rabies","volume":"18","author":"Borhani","year":"2015","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.vaccine.2017.11.047_b0100","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nm0898-949","article-title":"DNA immunization protects nonhuman primates against rabies virus","volume":"4","author":"Lodmell","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2017.11.047_b0105","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0264-410X(99)00247-9","article-title":"Immunization of dogs with a DNA vaccine induces protection against rabies virus","volume":"18","author":"Perrin","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.047_b0110","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1051\/vetres:2007054","article-title":"Intradermal DNA vaccination in ear pinnae is an efficient route to protect cats against rabies virus","volume":"39","author":"Tesoro-Cruz","year":"2008","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2017.11.047_b0115","first-page":"221","article-title":"Rabies DNA vaccination by the intranasal route in dogs","volume":"125","author":"Tesoro-Cruz","year":"2006","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2017.11.047_b0120","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1016\/S0264-410X(00)00475-8","article-title":"Post-exposure DNA vaccination protects mice against rabies virus","volume":"19","author":"Lodmell","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.047_b0125","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1016\/j.vaccine.2008.09.083","article-title":"Efficient post-exposure prophylaxis against rabies by applying a four-dose DNA vaccine intranasally","volume":"26","author":"Tesoro-Cruz","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.047_b0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0264-410X(98)00196-0","article-title":"Studies on the structures and antigenic properties of rabies virus glycoprotein analogues produced in yeast cells","volume":"17","author":"Sakamoto","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.047_b0135","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1128\/jvi.64.8.3804-3809.1990","article-title":"Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine","volume":"64","author":"Dietzschold","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0140","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1099\/0022-1317-70-2-291","article-title":"Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein","volume":"70","author":"Bunschoten","year":"1989","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1348-0421.2008.00016.x","article-title":"Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of rabies virus, by phage display technology","volume":"52","author":"Zhao","year":"2008","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0150","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1099\/0022-1317-74-8-1539","article-title":"Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein","volume":"74","author":"Van der Heijden","year":"1993","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0155","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1016\/j.vaccine.2008.10.020","article-title":"A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals","volume":"26","author":"Niederh\u00e4user","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.047_b0160","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.11.047_b0165","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/0-387-34134-X_17","article-title":"A minimum CR2 binding domain of C3d enhances immunity following vaccination","volume":"586","author":"Bower","year":"2006","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0170","series-title":"Molecular cloning: a laboratory manual","author":"Sambrook","year":"2001"},{"key":"10.1016\/j.vaccine.2017.11.047_b0175","series-title":"Laboratory techniques in rabies","author":"Kaplan","year":"1996"},{"key":"10.1016\/j.vaccine.2017.11.047_b0180","article-title":"Reduction of animal suffering in rabies vaccine potency testing by introduction of humane endpoints","author":"Takayama-Ito","year":"2016","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2017.11.047_b0185","doi-asserted-by":"crossref","first-page":"202","DOI":"10.7774\/cevr.2014.3.2.202","article-title":"Immunogenicity and efficacy of a plasmid DNA rabies vaccine incorporating Myd88 as a genetic adjuvant","volume":"3","author":"Ullas","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2017.11.047_b0190","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3748\/wjg.v10.i14.2072","article-title":"Contribution of C3d\u2013P28 repeats to enhancement of immune responses against HBV-preS2\/S induced by gene immunization","volume":"10","author":"Wang","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0195","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nri3689","article-title":"Follicular dendritic cells: dynamic antigen libraries","volume":"14","author":"Heesters","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-065X.2007.00556.x","article-title":"Complement receptors CD21 and CD35 in humoral immunity","volume":"219","author":"Roozendaal","year":"2007","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2017.11.047_b0205","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coi.2014.02.010","article-title":"Clonal and cellular dynamics in germinal centers","volume":"28","author":"Victora","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0210","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.vaccine.2017.11.047_b0215","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.1994.1105","article-title":"Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus","volume":"199","author":"Xiang","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.11.047_b0220","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1016\/j.vaccine.2010.03.039","article-title":"The immune response to rabies virus infection and vaccination","volume":"28","author":"Johnson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.047_b0225","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"Crotty","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2017.11.047_b0230","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.4049\/jimmunol.171.10.5165","article-title":"CD8 T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine","volume":"171","author":"Curtsinger","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.11.047_b0235","doi-asserted-by":"crossref","first-page":"E6639","DOI":"10.1073\/pnas.1606050113","article-title":"Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination","volume":"113","author":"Tam","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.11.047_b0240","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","article-title":"CD8 (+) T cells: foot soldiers of the immune system","volume":"35","author":"Zhang","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2017.11.047_b0245","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.vaccine.2016.12.069","article-title":"Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine","volume":"35","author":"Luo","year":"2017","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17316110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17316110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:27Z","timestamp":1759400727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17316110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0264410X17316110"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}